OpenSourceMalaria / OSM_To_Do_List

Action Items in the Open Source Malaria Consortium
82 stars 13 forks source link

Update from MCPHS on Synthesis of Reversed Amides #487

Open MedChemProf opened 7 years ago

MedChemProf commented 7 years ago

This is a long overdue update on our synthetic attempts to synthesize a few analogs of the 'Reversed Amides' as part of the overall SAR of Series 4. It has taken us much longer than originally expected to make these compounds. The Reversed Amide has been discussed previously in issue #301, #352 and #358. Our initial approach was to synthesize the azide which was then planned to be reduced to give the amine. This strategy worked on small scale and is detailed in ELN experiments CCS-3-2 and CCS-4-1. image1

On scale-up of the amine however, none of the amine was obtained, instead the intermediate iminophosphorane was isolated. Experiments TL-4-2 and TL-4-3. image2

Attempted hydrolysis of the iminophosphorane using the more common basic methods (heating with either aq. NaOH / THF or NH4OH / MeOH) failed to force the reaction to completion. (Experiment CCS-5-1). It was later discovered that the hydrolysis could be forced using acidic conditions, but the reaction was very slow (Experiment NA-7-2). image3

Prior to finding the acidic hydrolysis conditions, the reduction of the azide was also achieved using either catalytic hydrogenation or borohydride reduction. Both of these methods did provide the amine product, but the yields were low and the product difficult to isolate during purification from a complex mixture of by-products. (Experiments BM-5-1 / NA-2-1 and NA-2-4). image4 image5

It was decided to just hydrolyze the iminophosphorane since it produced pure amine product instead of trying to find more optimal reduction conditions for the azide. The amine however, proved to be unreactive with standard coupling conditions. Forcing conditions did produce some product which could be identified by NMR and LCMS, but the material was significantly contaminated with by-products. While the product was identified in the mixtures, we were unable to purify adequately via silica gel column chromatography or via preparative TLC. We did not have access to a Prep HPLC which would have allowed us to isolate the clean product. The figures below list the temperature being raised to 65C, but they were also repeated at as high as 110C-120C with mostly additional decomposition and resulted in very little extra product being formed. image6

Above attempts are detailed in Experiments CCS-6-1, NA-3-1, NA-3-2, FG-5-1, FG-5-2, FG-5-3, FG-5-4. An attempt to produce the urea also did not result in any reaction. Starting material only remained (Experiment VD-4-1). image7

It was then decided to abandon the acylation of the amine for the time being and focus on a different synthetic route to the desired Reverse Amides. Toward this end, a new core was synthesized containing a para-cyanophenyl group instead of a para-chloro. This was done in order to avoid any competition with a metal catalyzed substitution at that position versus the chloride on the pyrazole ring. (Experiments JH-5-1, JH-5-2 and JH-7-1). image8 image9

We are now back in touch with my contact at the Broad Institute and OSM-W-6 and OSM-W-7 will be sent for testing in the very near future.

mattodd commented 7 years ago

Yes, that's absolutely great, Chase. Interesting write-up (full marks awarded for linking to the lab book pages). So you're all set on bio evaluation, ideally vs standard controls so that we can be sure we can compare the data for the first Series 4 paper.

The fact that that amidation works implies we could access a bunch of other compounds that way, should yours prove to be active. Given the change you're making to the electron density of the ring, it'd be very nice to have them evaluated in the Aldehyde Oxidase assay. Might you be able to send some to Scott Obach when we do, as per #485 ?

MedChemProf commented 7 years ago

@mattodd We still have some MMV639565 which we will send along with the new compounds as a standard. We used this same compound as a standard/reference when we sent out last round of compounds. I also will be sending an extra quantity of MMV639565 since my contact at the Broad said that she could help us profile its PfATP4 activity. They run compounds against a panel of mutants that have been generated in resistance selections with the spiroindolone, NITD609, or the St. Jude's compound, SJ733. They also have an ongoing collaborative project with Elizabeth Winzeler's lab at UCSD where they have a panel of PfATP4 mutants for counter screening. I don't have all the details, but I am hoping the additional profiling may help us out. I am trying to get the compounds out the door this week.

I think we should have a little extra of the OSM-W-7 to send to Scott Obach. Where can I find the info on the shipping details? Thanks.

MFernflower commented 7 years ago

@MedChemProf

Would it be possible to make that urea from benzoic acid (benzoyl azide) and OSM-W-2 via Curtius Rearrangement?

I know it uses azides but it seems like it's worth a shot!

http://www.organic-chemistry.org/abstracts/lit1/511.shtm

MedChemProf commented 7 years ago

We have no plans to follow up with the urea.

MedChemProf commented 7 years ago

@mattodd We just received the assay results for the reversed amides. I have already added the results to the tracking spreadsheet. OSM-W-6 was marginally active Dd2 EC50=2.931uM and 3D7 EC50=5.418uM. OSM-W-7 was inactive with EC50's >10 for both cell lines. We used OSM-S-272 (OSM-W-272) as the internal standard and it repeated as it did from an earlier screen (Dd2 EC50=0.0467uM and 3D7 EC50=0.0918uM) osm-w-6 osm-w-7 osm-w-272

mattodd commented 7 years ago

Nice data @MedChemProf - very useful data point, though shame about the inactivity. Able to post the assay protocol somewhere, or reference it? Will need for publication, obv. One could suggest shortening the chain by another CH2, to see if there's a trend, but I'm not so sure.

MedChemProf commented 7 years ago

I have references for the assay and it has been posted on some of the other threads.

MedChemProf commented 7 years ago

I was thinking about coupling the difluorobenzamide to test that. We will see if we can get that one made.

mattodd commented 6 years ago

Hi @MedChemProf . @clairelittler did a nice job in summarizing the content of your results in this Issue. I’ve also checked/tweaked what she wrote. I think we’re done and I’d like to close this Issue. Summary of what we’ve done (to ensure this page is not orphaned):

1) Synthesis summarized here 2) SAR summarized here 3) Difluorobenzamide coupling product mentioned here as possible compound to make (exploration of linker length, I guess), so added to DCNYS with link back here. 4) Urea linked in DCNYS

Questions:

a) Mention is made of OSM-W-272, but was this a sample of OSM-S-272, or was it re-synthesized locally? We should be careful about code/identifier proliferation.

b) Thanks for adding the compounds to Master List for OSM-W-1 thru OSM-W-7, and the repeat of OSM-S-272. The Broad assay is different from others used to evaluate potency so I see you’ve added new columns to the Master List, which is great. In the corresponding assay sheet, could you add in an entry for the Broad assay (after the Batra assay) that links to lab notebook entries where those procedures are used (see column J).

Once those last two questions are resolved, we can close. By the way I think this Issue is a nice model of what Issues are for. Results were summarized, with links back to primary data. Suggestions were made by others. The content has been incorporated into the wiki (with primary files posted to Github), so as to make entry into a paper simple. Loose ends have been posted for potential follow-up. Nothing is orphaned. Issue is closed when complete.

MedChemProf commented 6 years ago

@mattodd I guess you can close the issue if you need. I was going to add several new compounds to the issue with antimalarial data. I am still waiting for the results. I also have been able to get MLM and HLM stability on a number of the compounds which I was also planning to post. A complete description of the compounds and their synthesis and experimental scan be found here: https://mynotebook.labarchives.com/share/MCPHS%2520MedChem/MzgzLjV8MzY3Ny8yOTUvVHJlZU5vZGUvMjYyNTI2OTc5OXw5NzMuNQ==

OSM-W-272 was a resynthesis of OSM-S-272.

In a nutshell, I have a lot of additional data to add, but I am currently hindered due to a personal reason and do not have an easy way to update. I am hoping to be in a position in about 3 weeks to be able to contribute again. The HLM/MLM data did confirm the reversed amides are less stable. We also made compounds to compare across para-cyano, chloro and sulfone in order to be able to do a matched pair analysis. Again, waiting for the antimalarial screening data. The only compound we failed at making was the reversed amide with no CH2 in the linker.